U.S. Senator Sanders says pharmacy middlemen commit to expanding weight-loss drug coverage if prices cut

U.S. Senator Bernie Sanders said on Tuesday he had received commitments from all major pharmacy benefit managers they would expand coverage of Novo Nordisk's (NOVOb.CO) popular diabetes and weight-loss medicines if the company lowered their list prices.